Neurotrope Profit Margin 2013-2018 | NTRP
Current and historical gross margin, operating margin and net profit margin for Neurotrope (NTRP) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Neurotrope net profit margin as of December 31, 2018 is 0%.
|Neurotrope Annual Profit Margins
|Neurotrope Quarterly Profit Margins
||Medical Products Manufacturing
Neurotrope, Inc. is focused primarily on the development and commercialization of Alzheimer's disease therapeutic products related diagnostics. The Company develops and markets two product platforms, including a non-invasive diagnostic test for Alzheimer's disease and a drug candidate called bryostatin for the treatment of Alzheimer's disease, both of which are in the clinical testing stage. Neurotrope, Inc. is based in Plantation, Florida.